Sign in
Taking people in United StatesNo phase

Tests a diabetes prevention program for young women with overweight or obesity

Tests a group weight and health program in women aged 18-39 planning pregnancy.

Key facts

Who runs it
Wake Forest University Health Sciences
Where
Winston-Salem, United StatesSee the site
Trial code
Registry title
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
Status
Recruiting
People taking part
403 people, planned
Started
8 Apr 2023
Expected to end
31 May 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • NDPP-NextGen
Record updated
27 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 18-39 with overweight or obesity who are not pregnant now but are likely to become pregnant within 24 months. It tests an online diabetes prevention class made for young women.

Age
18 to 39 years
Sex
Female (biologically female, all gender identities)
Disease stage
Overweight or obesity: BMI 25 kg/m2 or higher (23 kg/m2 or higher if Asian race)
Earlier treatment
Cannot have taken part in the NDPP before, had bariatric surgery, used GLP-1s in the last year, or be getting clinical obesity treatment now.

Main reasons for not taking part

  • Currently pregnant
  • Type 1 or type 2 diabetes
  • Long-acting contraception (IUD, implant, injection) planned for more than 1 year
  • Medical procedures or conditions that stop pregnancy, or unsuccessfully trying to conceive for 12 months or more
  • Prior NDPP participation, bariatric surgery or GLP-1 use in the last year

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Established patient at Denver Health or Atrium Health Wake Forest Baptist
  • Biologically female (inclusive of all gender identities)
  • Aged 18-39 years
  • English- or Spanish-speaking
  • BMI ≥25 kg/m2 (≥23 kg/m2 if Asian race)
  • Activities that lead to pregnancy in past 3 months
  • Interested in pregnancy within 24 months, including:; High interest (actively trying to conceive); General interest (not actively trying but wanting to become pregnant in the foreseeable future); Neutral interest (not planning pregnancy or using contraception for religious reasons)

Who cannot take part

  • Long-acting contraceptives (intrauterine device, implant, injection) with plans to continue for >1 year (barrier \& short-acting hormonal contraception permitted given ease of discontinuing to facilitate pregnancy)
  • Prior participation in the NDPP
  • Currently receiving clinical obesity treatment
  • Non-gestational diabetes (type 1, type 2)
  • Medical procedures (e.g., tubal ligation, hysterectomy) or conditions that impede pregnancy
  • History of bariatric surgery
  • Currently pregnant
  • Documented infertility or unsuccessfully trying to conceive for ≥12 months
  • Use of GLP-1s in last year

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 39 years old?

Where in United States

  • Wake Forest University Health SciencesWinston-Salem, United StatesContact: Katherine A Sauder, PhDTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to test an enhanced version of the National Diabetes Prevention Program (NDPP-NextGen) that is tailored to young women in childbearing years. The investigators will recruit 360 women aged 18-39 years with overweight/obesity who are not currently pregnant, but likely to conceive within 24 months. Women will be randomized to NDPP-NextGen or a usual care control group. The NDPP-NextGen group will participate in the adapted NDPP online group class across 12 months, and the control group will get a packet of information about how to be healthy before, during and after pregnancy.

Read full original descriptionShow less

The main goals of the study are:

1. to assess effects of NDPP-NextGen on pre-pregnancy blood sugar and early pregnancy BMI 2. to assess effects of NDPP-NextGen on weight gain and behavioral outcomes during pregnancy 3. to explore effects of NDPP-NextGen on infant's percentage of fat tissue at birth

All participants will complete up to 4 research visits: baseline, conception, mid-pregnancy, and delivery. These visits will include:

1. Questionnaires about health, diet, activity, smoking, self-confidence, and depression 2. Body size measurements 3. Fasted blood draws

Participants will also be asked to weigh themselves weekly using home scales that are connected to the research database. At the delivery visit, investigators will measure the baby's body size and collect a cord blood sample.

The 2 groups in the trial

  • Healthy LifestyleTreatment being tested

    Women in the Healthy Lifestyle group will be invited to attend the online NDPP-NextGen class which will cover how to eat healthy, be active, and lose weight before getting pregnant. The classes will be led by a trained Lifestyle Coach. Each class lasts about 1 hour. Classes initially meet about once a week (for the first 6 months), then twice a month (for the next 3 months), and then once a month (for the last 3 months). Classes will meet virtually through video-conference. Lifestyle coaches will also call participants in between classes to discuss how participants are doing, answer questions, and provide reminders for upcoming classes. Prior to the first class, women will also participate in a "pre-session" designed to increase NDPP engagement via discussion of diabetes risks and treatment options (i.e., clarify relevance) and motivational interviewing to resolve barriers.

    Treatment: NDPP-NextGen

  • Healthy WomenNo study treatment, for comparison

    Women in the Healthy Women group get a packet of information standardly given in OB clinics about how to be healthy before, during and after pregnancy.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
Plain-language title
Tests a diabetes prevention program for young women with overweight or obesityGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Criteria questions
Built from NCT05674799, who can take part
Record updated
27 February 2026